BLACR
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR
Delisted
BLACR was delisted on the 14th of February, 2025.
31 hedge funds and large institutions have $798K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EAM
1
Exos Asset Management
New York
|
$27.2K |
2 |
SOA
2
Sea Otter Advisors
Miami,
Florida
|
$17.1K |
3 |
BI
3
Bulldog Investors
Saddle Brook,
New Jersey
|
$2.67K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$3 |
Top Sellers
1 |
SFM
1
Spartan Fund Management
Toronto, Ontario,
Canada
|
$9.88K |
2 |
WC
2
Wealthspring Capital
West Harrison,
New York
|
$2.24K |
3 |
FTUS
3
Flow Traders U.S.
New York
|
$2K |
4 |
CS
4
Clear Street
New York
|
$28.6K |